| Document |
Document Title |
|
JPS60222496A |
NEW MATERIAL:A compound shown by the formula I (X is hydroxy, Y is alkali metallic salt of carboxyethyl, or X and Y together with neighboring carbon atom form lactone ring shown by the formula II). EXAMPLE: 17-Hydroxy-6β-,7β-methylene-...
|
|
JPS6044318B2 |
1512400 16,17-Naphthopregnenes E R SQUIBB & SONS Inc 13 Nov 1975 [25 Nov 1974] 46902/75 Heading C2U The invention comprises #4 and #1'4 steroids of formula wherein R 1 is Cl, F or OH; R1 1 is H; or R 1 and R1 1 together are oxo; R 2 is H...
|
|
JPS60174798A |
Antiinflammatory activity is exhibited by pregnenes having the structural formula wherein R1 is hydrogen, hydroxy, halogen, or acyloxy; R2 and R3 are each hydrogen, R2 and R3 are each methyl, R2 and R3 are each alkylthio, R2 is hydrogen ...
|
|
JPS60139685A |
PURPOSE: To obtain the titled compund which is a plant growth promoting substance in high yield in short steps, by mesylating the hydroxyl group of an easily available brassicasterol, reacting the resultant reaction product with sodium a...
|
|
JPS6030517B2 |
Estrene-3,17-diones of the formula wherein X is oxo, or ketalized oxo, preferably alkylenedioxy of 2-6 carbon atoms or o-phenylenedioxy; DELTA IS A CARBON ATOM LINKED TO THE ADJACENT CARBON ATOMS BY A DOUBLE BOND AND TWO SINGLE BONDS; R1...
|
|
JPS6017794B2 |
Homobrassinolide of the formula:which shows a plant growth promoting activity.
|
|
JPS6075496A |
7 alpha -Alkoxycarbonyl-3-oxo-17 alpha -pregn-4-ene-21,17-carbolactones and their 21-carboxylic acid salts of the general formula I are described, in which R is an alkyl group with 1 to 4 carbon atoms is a CC single or CC double bond or ...
|
|
JPS6069096A |
Steroids of the formulaand a therapeutic composition containing same which are useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents.
|
|
JPS6038397A |
New 15,16-methylene-17 alpha -pregna-4,6-diene-21-carboxylic acid salts of formula I (I) wherein R1 and R2 each alone is hydrogen or together they form an additional CC bond or a methylene group, M is an alkali metal, and the methylene g...
|
|
JPS6034990A |
17-haloethynyl steroids of the partial formula wherein R1 is hydrogen or methyl, R2 is alkyl of 1-4 carbon atoms, acyl of 1-7 carbon atoms, trimethylsilyl, 2-tetrahydropyranyl, or nitrate, X is bromine or iodine, and V is methylene, ethy...
|
|
JPS5945037B2 |
|
|
JPS5942680B2 |
The invention is concerned with new chemical compounds being the hemiesters of steryl glycosides, methods of preparing these hemiesters, and pharmaceutically, particularly anti-inflammatory, compositions containing the new hemiesters.
|
|
JPS59139400A |
NEW MATERIAL:A compound of formula I (X is H, halogen, hydroxyl; Y is H, lower alkyl, halogen, alkylthio; X and Y may incorporate to form a ring; Z1 is hydroxyl; Z2 is carboxyethyl alkali metal salt; Z1 and Z2 may incorporate together wi...
|
|
JPS5927360B2 |
The synthesis of 25-hydroxycholesterol from animal bile starting materials in which hyodeoxychloic acid or an ester thereof is converted to the 3 beta -hydroxy-5-cholenic acid alkyl ester, and then converted to 3 beta -hydroxy-25-cyano-5...
|
|
JPS5919559B2 |
|
|
JPS5973600A |
PURPOSE: An ovulatory inducing agent, containing 24-methylenecycloartanol as a main constituent, and useful as a remedy for amenorrhea, dysmenorrhea, ovulatory disorder, menstrual cycle abnormality, etc. CONSTITUTION: An ovulatory induci...
|
|
JPS5970700A |
7 alpha -substituted-17 alpha -pregn-4-ene-21, 17-carbolactones and -21-carboxylic acid salts of formula I. wherein C1@@@C2 is a C-C single or C=C double bond, R is a saturated or unsaturated, straight-chain or branched aliphatic radical...
|
|
JPS5936623A |
PURPOSE: The titled pharmaceutical, containing a 9,19-cyclolanostane derivative isolated as a component of Astragali Radix as an active constituent, capable of stimulating a host to promote the production of interferon, and useful as an ...
|
|
JPS591280B2 |
A series of novel steroidal[ 16 alpha , 17-d]cyclohexenes having a 9-fluoro group is disclosed herein for use as anti-inflammatory agents.
|
|
JPS5850239B2 |
1455220 7-Substituted-spiroxane steroids G D SEARLE & CO 12 Sept 1974 [14 Sept 1973] 39799/74 Heading C2U Novel steroids of the formula (wherein " alkyl " contains 1-7 carbon atoms and #1 is optional) are prepared by contacting 41,51 - d...
|
|
JPS58188900A |
1 alpha ,2 alpha ;6 beta ,7 beta ;15 beta ,16 beta -trimethylene-3-oxo-17 alpha -pregn-4-ene-21,17-carbolactone is prepared from 6 beta ,7 beta ;15 beta ,16 beta -dimethylene-3-oxo-17 alpha -pregna-1,4-diene-21,17-carbolactone with dimet...
|
|
JPS5843400B2 |
PURPOSE:To prepare the titled compound useful as a medicine for autonomic imbalance, etc., easily, in high yield, by the heat isomerization of a 24-methylenecycloaltanol organic acid ester or a composition containing the ester using iodi...
|
|
JPS58150600A |
PURPOSE: To prepare a uniform solution or a solid substance, by dissolving a ferulic acid ester of 24 methylenecycloartanol useful as an antioxidant for products of fats and oils in a fatty acid ester, etc. under heating, adding an edibl...
|
|
JPS5829317B2 |
1425636 15,16 - Methylene - estr - 4 - enes SCHERING AG 12 Feb 1973 [11 Feb 1972] 6821/73 Heading C2U [Also in Division A5] Novel steroids of the formula wherein R1 is C 1-5 alkyl; R2 is H or acyl; R3 is H or an optionally substituted al...
|
|
JPS5812280B2 |
|
|
JPS5811959B2 |
NEW MATERIAL:Alkali metal salt of cycloartenol succinic acid ester of formula (M is Na or K). EXAMPLE:Sodium cycloartenyl succinate. USE:Hydrophilic medicine having little toxicity and few side effects, and a higher effect than known cyc...
|
|
JPS5811960B2 |
NEW MATERIAL:Alkali metal salt of cyclobranol succinic acid ester of formula (M is Na or K). EXAMPLE:Sodium cyclobranyl succinate. USE:Hydrophilic medicine having little toxicity and few side effects, and higher effect than known cyclobr...
|
|
JPS5811880B2 |
15 alpha , 16 alpha -METHYLENE-4-PREGNENES OF THE FORMULA WHEREIN R1 is a lower alkyl and R2 is alkanoyl of 1-18 carbon atoms have gestagenic activity.
|
|
JPS5821619A |
PURPOSE: A solvent that does not dissolve oryzanol is added to an organic solution of crude or purified oryzanol to effect partial precipitation, thus economically producing high-purity constituents used in medicines and cosmetics. CONST...
|
|
JPS57183783A |
The invention is concerned with a process for the preparation of 1 hydrogen or hydroxy cholesterol derivatives and intermediates therefor. The compounds of the present invention are useful as intermediates in the preparation of 24,25-dih...
|
|
JPS57149248A |
NEW MATERIAL:Cycloartenol ferulic ester. USE: A drug having pharmaceutical and physioligical action of oryzanol, useful as a promotor for growth and an estrous agent for animal, a remedy for menopausal disorder or hepatic disorder, a cho...
|
|
JPS5636364B2 |
A method and an apparatus for detecting and recording the number of phenomena, for instance of defects of a product continuously manufactured, wherein a graphic record is made on a recording tape in a direction transverse to the advancin...
|
|
JPS56500538A |
This invention relates to isotopically labeled vitamin D compounds, including radiolabeled vitamin D compounds of high specific activity, methods for their preparation, and novel intermediates in their synthesis. The radiolabeled vitamin...
|
|
JPS5614680B2 |
25-Hydroxycholesterol, an intermediate in the preparation of biologically important metabolites of Vitamin D3 is synthesized in a multi-step process from pregnenolone.
|
|
JPS5614679B2 |
1445237 i-Steroids; 25-hydroxycholesterol F HOFFMANN-LA ROCHE & CO AG 20 May 1974 [21 May 1973] 40334/75 Divided out of 1445236 Headings C2U and C2C The invention comprises compounds of formulae wherein R1 is hydroxy, C 1-8 alkoxy, pheny...
|
|
JPS55155000A |
The present disclosure is directed to 6-lower alkoxy-25,26-(lower alkyl or lower alkylene)methylene dioxy-3,5-cyclocholest-22-ene derivatives which are useful in the manufacture of 25,26-dihydroxycholecalciferol.
|
|
JPS55124800A |
A mixture of phytosterols containing stigmasterol, sitosterol and campesterol is… a) converted to the i-methyl ethers of the phytosterols,… b) the i-methyl ethers are ozonized,… c) the ozonide is reduced to form a mixture of 6- bet...
|
|
JPS5555200A |
The steroids of the present invention have been found to be useful as male contraceptives when administered orally. Upon cessation of administration of the male contraceptive steroids of the present invention the male promptly regains no...
|
|
JPS5545677A |
4,5-methano-bufadienolide-rhamnosides of the formula I I where R1 is hydrogen or alkyl or acyl of 1 to 4 carbon atoms, R2 and R3 are identical or different and each is hydrogen or alkyl or acyl of 1 to 4 carbon atoms, or both together ar...
|
|
JPS559071A |
Compounds of the general formula in which R' is hydrogen or a methyl radical; R is a hydroxyl, acetoxy, arylaminocarbonyloxy, alkylaminocarbonyloxy radical; Z is hydrogen or a lower alkyl, or R and Z together are oxygen. These compounds ...
|
|
JPS552440B2 |
|
|
JPS557295A |
Steroids having the formula wherein R1 is alkyl, aryl or arylalkyl; R2 and R3 are the same or different and are hydrogen, alkyl or aryl; R4 is hydrogen and R5 is hydroxy or together R4 and R5 are =O; and R6 is hydrogen, methyl or fluorin...
|
|
JPS54130550A |
Cholestane derivs. of formula (I) are new: (where R1 and R2 together form a bond, or R1 is OH and R2 is H; and (a) R3=R4=R5=H, or (b) R3+R4=0 and R5=H, or (c) R3+R5=0 and R4=H, or (d) R3 and R5 together form a bond and R4=H, or (e) R3+R4...
|
|
JPS54128573A |
Novel cholestane derivatives, which can be used as intermediates in the manufacture of 25,26-dihydroxy-cholecalciferol, as well as a process for their preparation is described.
|
|
JPS5420488B2 |
|
|
JPS53141249A |
pg,1 Steroids having the formula wherein X is R1 is alkyl, aryl or acyloxyalkyl; R2 and R3 are the same or different and are hydrogen, alkyl, alkoxy, carboalkoxy, formyl, hydroxy, halogen, phenyl or cyano, with the proviso that when R2 a...
|
|
JPS53141258A |
Compounds of the formula I (I), wherein R2 is hydrogen or an organic acid residue; R3 is methyl or ethyl; R4 is hydrogen or methyl; +TR wherein R1 is lower alkyl; and and when R2 is a dibasic acid residue, the physiologically acceptable ...
|
|
JPS53128829A |
An installation for damping vibrations of a drive axle, especially of a rear axle, of motor vehicles, in which the driving pinion of the differential gear which meshingly engages with the spur bevel gear, is driven by way of a universal ...
|
|
JPS5339425B2 |
|
|
JPS53119858A |
|
